Omeros Corporation Moves Closer To IPO, Sets Price Goal  
9/17/2009 7:59:51 AM

Bookmark and Share -- Omeros, the Seattle biotech company that’s attempting to pull off the first IPO from a Washington company in two years, took a step closer toward its goal today by updating its prospectus and stating it hopes to go public at a range of $10 to $12 a share.